Abstract:Abstract Background: A diet rich in colorful fruits and vegetables is effective for the prevention of various inflammation-induced cancer types. Mechanistically, this effect has been attributed to the potent antioxidant properties of flavonoid molecules. However, contrary to observations in mice, the success of flavonoids in human dietary cancer prevention trials is often dampened due to large interpersonal variation. Antioxidant activity alone does not explain this variability, suggesting there is an additional important variable that has not been accounted for. Since flavonoids have a poor bioavailability and predominantly passage into the large intestine, we hypothesize that gut microbial metabolism is essential for flavonoid bioactivity in colon cancer prevention. Goals and Objectives: The goal of this study was to evaluate the impact of microbiota composition on the efficacy of dietary flavonoids in preventing intestinal tumorigenesis. Methods: We used the adenomatous polyposis coli - multiple intestinal neoplasia (ApcMin/+) mouse model, which is genetically predisposed to develop adenomas along its gastrointestinal tract. Development of these adenomas and eventual adenocarcinoma formation is further influenced by factors such as inflammation, dietary input and the gut microbiota. Animals were fed a control high fat diet (HFD) or prevention diets consisting of 1% berry extract, 1% purified flavonoid or 1% microbial catabolite, all on the HFD background. The contribution of the microbiota was modelled by including experimental groups that received an antibiotic cocktail in their drinking water throughout the course of the experiment. For these animals, microbiota community composition was determined by 16S rRNA sequencing, plasma was collected for histological profiling and metabolomics analysis and end-point measurements of intestinal tumor numbers and size were performed. Results: Supplementation with berry extract significantly reduced colon tumor numbers and incidence in male, but not in female mice. This effect was negated in mice on antibiotic drinking water, implicating the involvement of the gut microbiota. Community analysis revealed a relative increase in Erysipelotrichaceae, Clostridia and Akkermansia in the berry supplemented versus HFD control mice. In addition, their systemic monocyte counts were reduced. Dietary supplementation with a major gut microbial flavonoid catabolite, did not reduce colon tumor formation, suggesting the functional involvement of different microbial metabolites. Conclusions: Our study demonstrates the involvement of the mouse gut microbiota in dietary prevention of colon tumor formation. These effects impact circulating monocytes and are linked to changes in the plasma metabolome. We are currently elucidating the microbial actors and associated molecular pathways involved. Citation Format: Beckey DeLucia, Jan Claesen. Dietary flavonoids prevent colon tumor formation in ApcMin/+ mice in a microbiome- and sex-dependent manner. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 4243.

The Chemoprotective Effects of Mammalian Lignans Enterodiol and Enterolactone in Non‐Transformed Colonocytes

The anti-cancer effect of flaxseed lignan derivatives on different acute myeloid leukemia cancer cells

Flaxseed Lignans Enhance the Cytotoxicity of Chemotherapeutic Agents against Breast Cancer Cell Lines MDA-MB-231 and SKBR3

The Effects Of Cellulose On Aom/Dss-Treated C57bl/6 Colorectal Cancer Mice By Changing Intestinal Flora Composition And Inflammatory Factors

Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets

Effects of Metabolites of the Lignans Enterolactone and Enterodiol on Osteoblastic Differentiation of MG-63 Cells

Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signaling.

Personalized Nutrition Using Microbial Metabolite Phenotype to Stratify Participants and Non-Invasive Host Exfoliomics Reveal the Effects of Flaxseed Lignan Supplementation in a Placebo-Controlled Crossover Trial

Chemopreventive Effects of Polysaccharides and Flavonoids from Okra Flowers in Azomethane/Dextran Sulfate Sodium-Induced Murine Colitis-Associated Cancer

The CYP1A1 connection between enterolactone and breast cancer risk

Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model

Chemoprevention of dietary digitoflavone on colitis-associated colon tumorigenesis through inducing Nrf2 signaling pathway and inhibition of inflammation

Flaxseed Ethanol Extracts’ Antitumor, Antioxidant, and Anti-Inflammatory Potential

Inhibitory Effects of Enterolactone on Growth and Metastasis in Human Breast Cancer

The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor

Pro-apoptotic and anti-angiogenic actions of 2-methoxyestradiol and docosahexaenoic acid, the biologically derived active compounds from flaxseed diet, in preventing ovarian cancer

Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives

The chemopreventive effect of 5-demethylnobiletin, a unique citrus flavonoid, on colitis-driven colorectal carcinogenesis in mice is associated with its colonic metabolites.

Abstract 4243: Dietary flavonoids prevent colon tumor formation in ApcMin/+ mice in a microbiome- and sex-dependent manner

Study of the Flaxseed Lignan on the Animal Model of Breast Cancer Prevention and the Relation with the Body Estrogen

Transforming growth factor alpha distribution in rectal crypts as a biomarker of decreased colon cancer risk in patients consuming cellulose